A large biopsy-confirmed study found that fatty liver–related cirrhosis is not limited to older adults. About one in four MASLD cirrhosis cases occurred before age 50.
The key article is “Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis” from the the 09/16/2026 issue of Clinical Gastroenterology & Hepatology.
Younger patients with type 2 diabetes, obesity, or inherited genetic risk were more likely to develop cirrhosis early. One major concern is that common screening tools such as FIB-4 include age in their calculations. Consequently, younger adults can receive reassuring scores even when significant liver scarring is present. In this study, standard thresholds missed almost one-third of the early-onset cases.
The practical message is that being young does not protect someone from advanced fatty liver disease. Adults under 50 with diabetes, obesity, or a family history of liver disease may warrant more proactive assessment—potentially including liver stiffness testing—even when routine bloodwork or an age-weighted score appears reassuring. The study identifies associations and does not establish new screening guidelines.
